Answers are grounded in this paper and cite their sources.
Diverse chemical biology applications, including targeted drug delivery and fluorescent labeling, rely on the site-selective functionalization of peptides. Nonribosomal peptide synthetases (NRPSs) install reactive building blocks directly into bioactive scaffolds, but current methods rely on externally supplied substrates and irreversible conjugation reactions. Here, we establish an integrated system for the de novo biosynthesis of nonribosomal peptides bearing the Diels-Alder (DA)-reactive amino acid 3-furylalanine (Fua). Rational engineering revealed mutations that switched specificity from phenylalanine to Fua across adenylation (A) domains. In a full assembly line context, the engineered gramicidin S synthetase site-specifically recruited biosynthetically provided Fua, forming Fua-modified gramicidin S. This analog exhibits enhanced antibacterial potency and reduced hemolytic activity. As intended, the Fua residue enabled DA-mediated fluorescent labeling of peptides integrated into cell membranes. This work introduces a de novo biosynthesis strategy of reversibly taggable natural products, expanding the interface between biosynthetic pathway engineering and bioorthogonal chemistry.
No takes yet. Share an insight, caveat, or question.
Ehinger et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: